Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".

Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE, Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G; Catastrophic Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2014 Feb;13(2):157-62. doi: 10.1016/j.autrev.2013.10.004. Epub 2013 Oct 19.

PMID:
24145009
2.

Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.

Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, Shoenfeld Y, Espinosa G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Autoimmun Rev. 2013 Sep;12(11):1085-90. doi: 10.1016/j.autrev.2013.05.004. Epub 2013 Jun 15.

PMID:
23777822
3.

Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.

Espinosa G, Rodríguez-Pintó I, Gomez-Puerta JA, Pons-Estel G, Cervera R; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies).

Semin Arthritis Rheum. 2013 Feb;42(4):417-23. doi: 10.1016/j.semarthrit.2012.05.005. Epub 2012 Jul 10.

PMID:
22784445
4.

Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.

Cervera R; CAPS Registry Project Group.

Lupus. 2010 Apr;19(4):412-8. doi: 10.1177/0961203309361353.

PMID:
20353979
5.

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".

Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G, Shoenfeld Y, Ingelmo M, Espinos G; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies).

J Autoimmun. 2009 May-Jun;32(3-4):240-5. doi: 10.1016/j.jaut.2009.02.008. Epub 2009 Mar 26.

PMID:
19324520
6.

Maintenance of reduction of pediatric distal radius fractures with a sugar-tong splint.

Denes AE Jr, Goding R, Tamborlane J, Schwartz E.

Am J Orthop (Belle Mead NJ). 2007 Feb;36(2):68-70.

PMID:
17405634
7.

Case 24-2005: a woman with estrogen-receptor-positive breast cancer.

Denes AE.

N Engl J Med. 2005 Nov 24;353(21):2304-5; author reply 2304-5. No abstract available.

8.

Low-dose aspirin in polycythemia vera.

Denes AE.

N Engl J Med. 2004 Apr 15;350(16):1683-5; author reply 1683-5. No abstract available.

PMID:
15088323
9.

A global suppressor motif for p53 cancer mutants.

Baroni TE, Wang T, Qian H, Dearth LR, Truong LN, Zeng J, Denes AE, Chen SW, Brachmann RK.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4930-5. Epub 2004 Mar 22.

10.

hADA3 is required for p53 activity.

Wang T, Kobayashi T, Takimoto R, Denes AE, Snyder EL, el-Deiry WS, Brachmann RK.

EMBO J. 2001 Nov 15;20(22):6404-13.

11.

Chronic lymphocytic leukemia remission following extra corporeal shock wave lithotripsy for urinary calculi.

Denes AE, Shalhav AL, Kovacs G, Clayman RV.

Am J Hematol. 1998 Jul;58(3):239-40.

12.

Chemotherapy with mitoxantrone in hormone-refractory prostate cancer.

Denes AE.

J Clin Oncol. 1997 Jan;15(1):410-1. No abstract available.

PMID:
8996172
13.

Chemotherapy in inflammatory breast cancer.

Denes AE.

J Clin Oncol. 1987 May;5(5):825. No abstract available.

PMID:
3572468
14.
15.

Cutaneous anergy and marrow suppression as complications of gastroplasty for morbid obesity.

Schneider SB, Erikson N, Gebel HM, Wedner HJ, Denes AE, Halverson JD.

Surgery. 1983 Jul;94(1):109-11.

PMID:
6857504
16.

Gestational carcinoma of the female breast.

Wallack MK, Wolf JA Jr, Bedwinek J, Denes AE, Glasgow G, Kumar B, Meyer JS, Rigg LA, Wilson-Krechel S.

Curr Probl Cancer. 1983 Mar;7(9):1-58. Review.

PMID:
6303698
17.

Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies.

Hoffman R, Bruno E, Elwell J, Mazur E, Gewirtz AM, Dekker P, Denes AE.

Blood. 1982 Nov;60(5):1173-8.

18.
19.

Phase I and preliminary phase II observations of high-dose intermittent 6-thioguanine.

Presant CA, Denes AE, Klein L, Garrett S, Metter GE.

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1109-13.

PMID:
7459896
20.

Chemotherapy for lung cancer.

Denes AE, Presant CA.

Ann Intern Med. 1979 Jan;90(1):125-6. No abstract available.

PMID:
420447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk